ArticleBioprocess and biosystems engineering2026
Controlling 3-hydroxyhexanoate mole fraction in poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) by altering enoyl-CoA hydratase (phaJ) ribosome-binding site in Cupriavidus necator H16.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Polyhydroxyalkanoate (PHA) is a bioplastic attracting interest as an alternative to petroleum-based plastics. Particularly, poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (P(3HB-co-3HHx)), which shows notable polymeric properties, is usually produced using the engineered Cupriavidus necator. Currently, production of P(3HB-co-3HHx) is primarily possible by engineering phaC, however, relatively rare study of controlling the expression of enoyl-CoA hydratase (phaJ
Indexed as
Identifiers
41074969What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.